Castle Biosciences stock price target raised to $90 from $70 at KeyBanc Capital Feb. 3, 2021 at 5:58 a.m. ET by Tomi Kilgore Castle Biosciences started at overweight with $70 stock price target at KeyBanc Capital Nov. 10, 2020 at 6:30 a.m. ET by Tomi Kilgore Castle Bioscien...
Ex-Dividend DateN/A Short Interest1.71M01/31/25 % of Float Shorted6.28% Average Volume372.36K Performance 5 Day -7.17% 1 Month -4.84% 3 Month -14.06% YTD -4.84% 1 Year 3.49% Analyst Ratings Sell Under Hold Over Buy Number of Ratings9Full Ratings ...
Dividend Ex-Date - Current Ratio 7.29 EPS Y/Y TTM 130.33% Oper. Margin 2.61% RSI (14) 23.40 Volatility 7.00% 5.87% Employees 761 Debt/Eq 0.06 Sales Y/Y TTM 51.09% Profit Margin 5.49% Recom 1.11 Target Price 39.67 Option/Short Yes / Yes LT Debt/Eq 0.05 EPS Q/Q 432.91% Payout 0.0...
Dividend Investing Value Investing Options Trading Growth Stocks Biotech Investing Tech Stocks Quantitative Investing Learn Investing Resources Investing Education Investing Strategies Retirement Investing Stock Market Sectors Stock Market Holidays & Hours After Hours Trading Portfolio Management Cryptocurrency Dividend...
Get the latest updates on Castle Biosciences, Inc. Common Stock (CSTL) after hours trades, after hours share volumes, and more. Make informed investments with Nasdaq.